75% CBD Directly Compressible Granulates to Transform CBD Oral Solid Dosage Systems

Tuesday, December 10, 2019 Drug News
Email Print This Page Comment bookmark
Font : A-A+

MIAMI, Dec. 10, 2019 /PRNewswire/ -- Imbucanna announced today the launch the world's first 75% concentrated directly compressible CBD.  CBDC-75 effectively allows even the smallest of manufacturer to quickly formulate all sorts of CBD oral solid dosage (OSD) forms in one easy step, and with elementary formulation knowledge.  The patent-pending granulates are a massive leap forward in CBD oral delivery technology, and alleviates the lack of content uniformity, use of solvents, production costs, and advanced formulation expertise needed to formulate regular tablets, chewables, ODTs, and other oral solid dosage forms of CBD. 

"The introductory 75% directly compressible CBD powder can be easily dry mixed with the customer's preferred filler-matrix, and compressed into strong orally disintegrating tablets (ODTs), chewables, mints, regular tablets, effervescent tablets, and other OSD forms of CBD with never before seen speed, ease, and low cost," said Leo Mendez, Imbucanna's Founder and CEO.  "Our CBDC-75 is the first in a series of directly compressible cannabinoid intermediates created to take the guesswork out of formulating a portfolio of hemp-derived oral solid dosage forms."

About Imbucanna:

Imbucanna is a pharmaceutical company that specializes in developing, producing, and marketing highly concentrated, hemp-derived intermediates for direct compression.  The company provides over 30 different base CBD oral dose formulations for free on imbucanna.com.  

Press Contacts:

Leo Mendez, CEOImbucanna.comleo@imbucanna.com201-744-5889

Cision View original content:http://www.prnewswire.com/news-releases/75-cbd-directly-compressible-granulates-to-transform-cbd-oral-solid-dosage-systems-300972523.html

SOURCE Imbucanna, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Premium Membership Benefits

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store